VolitionRX Ltd
VNRX0.680USD
+0.056+8.96%
收盘 09/19, 16:00（美东）报价延迟15分钟
70.71M总市值
亏损市盈率 TTM
关于 VolitionRX Ltd 公司
VolitionRx Limited 是一家跨国表观遗传学公司，专注于推动表观遗传学科学的发展。该公司致力于通过早期检测以及疾病和治疗监测，挽救生命并改善患有致命疾病的人和动物的治疗效果。该公司通过其子公司开发和商业化血液检测，以帮助诊断和监测一系列疾病，包括癌症和与 NETosis 相关的疾病，例如败血症。其主要支柱是 Nu.Q Vet、Nu.Q NETs、Nu.Q Discover、Nu.Q Cancer 和 Capture-PCR。Nu.Q Vet Cancer Test 可作为狗的癌症筛查测试在市场上销售。Nu.Q NETs 正在监测免疫系统以挽救生命。Nu.Q Discover 是分析核小体的完整解决方案。Nu.Q Cancer 监测疾病进展、治疗反应和微小残留疾病。Capture-PCRTM 正在从血浆样本中分离和捕获循环肿瘤衍生 DNA，以进行早期癌症检测。
公司简介
公司代码VNRX
公司名称VolitionRX Ltd
上市日期Feb 06, 2015
CEODr. Jasmine Kway
员工数量85
证券类型Ordinary Share
年结日Feb 06
公司地址1489 West Warm Springs Road
城市HENDERSON
上市交易所NYSE American Consolidated
国家United States of America
邮编89014
电话17024251561
网址https://volition.com/
公司代码VNRX
上市日期Feb 06, 2015
CEODr. Jasmine Kway
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Guy Archibald Innes
Mr. Guy Archibald Innes
Independent Director
Independent Director
2.88M
+2.78%
Mr. Cameron John Reynolds
Mr. Cameron John Reynolds
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.18M
+0.69%
Dr. Jacob Vincent Micallef
Dr. Jacob Vincent Micallef
Chief Scientific Officer
Chief Scientific Officer
456.18K
-4.51%
Mr. Terig Hughes
Mr. Terig Hughes
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
388.15K
+7.22%
Dr. Salvatore Thomas Butera
Dr. Salvatore Thomas Butera
Chief Executive Officer of Volition Vet
Chief Executive Officer of Volition Vet
341.11K
+8.80%
Dr. Jasmine Kway
Dr. Jasmine Kway
Chief Executive Officer of Singapore Volition
Chief Executive Officer of Singapore Volition
203.61K
+6.54%
Dr. Alan Colman, Ph.D.
Dr. Alan Colman, Ph.D.
Independent Director
Independent Director
203.55K
-10.28%
Mr. Gael Forterre
Mr. Gael Forterre
Chief Commercial Officer
Chief Commercial Officer
166.43K
+4.37%
Mr. Nicholas Plummer
Mr. Nicholas Plummer
Group General Counsel
Group General Counsel
164.38K
+13.52%
Dr. Andrew Retter
Dr. Andrew Retter
Chief Medical Officer
Chief Medical Officer
151.16K
+9.71%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Guy Archibald Innes
Mr. Guy Archibald Innes
Independent Director
Independent Director
2.88M
+2.78%
Mr. Cameron John Reynolds
Mr. Cameron John Reynolds
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.18M
+0.69%
Dr. Jacob Vincent Micallef
Dr. Jacob Vincent Micallef
Chief Scientific Officer
Chief Scientific Officer
456.18K
-4.51%
Mr. Terig Hughes
Mr. Terig Hughes
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
388.15K
+7.22%
Dr. Salvatore Thomas Butera
Dr. Salvatore Thomas Butera
Chief Executive Officer of Volition Vet
Chief Executive Officer of Volition Vet
341.11K
+8.80%
Dr. Jasmine Kway
Dr. Jasmine Kway
Chief Executive Officer of Singapore Volition
Chief Executive Officer of Singapore Volition
203.61K
+6.54%
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 8月23日 周六
更新时间: 8月23日 周六
持股股东
股东类型
持股股东
持股股东
占比
Cotterford Co., Ltd.
11.16%
Lagoda Investment Management, L.P.
10.88%
Armistice Capital LLC
7.89%
Innes (Guy Archibald)
2.68%
Reynolds (Cameron John)
2.02%
其他
65.37%
持股股东
持股股东
占比
Cotterford Co., Ltd.
11.16%
Lagoda Investment Management, L.P.
10.88%
Armistice Capital LLC
7.89%
Innes (Guy Archibald)
2.68%
Reynolds (Cameron John)
2.02%
其他
65.37%
股东类型
持股股东
占比
Investment Advisor
13.11%
Corporation
12.09%
Hedge Fund
8.10%
Individual Investor
7.33%
Investment Advisor/Hedge Fund
1.04%
Research Firm
0.04%
其他
58.29%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
78
41.39M
40.30%
+860.69K
2025Q1
83
44.42M
46.85%
+2.70M
2024Q4
82
41.53M
44.82%
+1.50M
2024Q3
82
38.59M
41.90%
+9.42M
2024Q2
82
28.77M
32.86%
+105.49K
2024Q1
84
28.22M
34.52%
+1.47M
2023Q4
87
26.17M
37.10%
+183.39K
2023Q3
91
25.37M
36.48%
-477.38K
2023Q2
98
25.03M
37.36%
-1.92M
2023Q1
127
25.94M
45.68%
-639.07K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Cotterford Co., Ltd.
12.01M
11.65%
--
--
Apr 25, 2025
Lagoda Investment Management, L.P.
10.19M
9.89%
+2.62M
+34.56%
Mar 31, 2025
Armistice Capital LLC
8.21M
7.97%
-275.46K
-3.25%
Mar 31, 2025
Innes (Guy Archibald)
2.81M
2.72%
+20.00K
+0.72%
Jun 03, 2025
Reynolds (Cameron John)
1.88M
1.83%
+12.50K
+0.67%
Jun 12, 2025
The Vanguard Group, Inc.
706.06K
0.69%
+69.39K
+10.90%
Mar 31, 2025
Concord International Inc.
1.01M
0.98%
--
--
Apr 25, 2025
Geode Capital Management, L.L.C.
761.95K
0.74%
+18.11K
+2.43%
Mar 31, 2025
Micallef (Jacob Vincent)
456.18K
0.44%
-21.53K
-4.51%
Jun 01, 2025
BlackRock Institutional Trust Company, N.A.
445.19K
0.43%
--
--
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
